9Cunha BA. The antibiotic treatment of community acquirednosocomialpneumonia. Med Clin North Am, 1995,79 (3) : 581.
10Chen DK, McGeer A, De Azavedo JC ,et al. Decreased susceptibility of streptococcus pneumoniae to flouroquinolones in Conada[ J]. N Engl J Med, 1999,341 : 233 - 239.
2Mandell LA, Wunderink RG, Anzueto A, et al. lntectious Diseases Society of America/Ameriean Thoracic Society consensus guidelines on the management of community- acquired pneumonia in adults [ J ]. Clin Infect Dis, 2007, 44 : s27-s72.
3Chalmers JD,Rutherford J. Can we use severity assessment tools to increase outpatient management of community- acquired pneumonia? [ J ]. Eur J Intern Med, 2012, 23 (5) :398-406.
4Pereira JM, Paiva JA, Rello J. Asseeing severity of patients with community-acquired pneumonia [ J ]. Semin Respir Crit Care Med,2012,33 (3) :272-283.
5Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Comparison of three predictive rules for assessing severity in elderly patients with CAP[ J ]. Int J Clin Pract, 2011,65(11 ) :1165-1172.
6Billeter A,Ttwina M,Seifert B,et al. Early serum procalcitonin, interleukin-6,and 24-hour lactate clearance : useful indicators of septic ilffections in severely traumatized patients [J]. World J Surg,2009,33 (3) :558-566.
7Nguyen HB, koomba M ,Yang J J, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shoek[J]. J Inlamm(Lond),2010,7:6-16.
8Jansen TC, Van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment [ J ]. Crit Care Med, 2009, 37 (10) : 2827-2839.
